BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
US Department of Justice
US Army
Express Scripts

Generated: December 13, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Omega-3-acid Ethyl Esters, and when can generic versions of Omega-3-acid Ethyl Esters launch?

Omega-3-acid Ethyl Esters is a drug marketed by Amneal Pharms, Apotex Inc, Par Pharm Inc, Strides Pharma, and Teva Pharms Usa. and is included in five NDAs.

The generic ingredient in OMEGA-3-ACID ETHYL ESTERS is omega-3-acid ethyl esters. There are thirteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the omega-3-acid ethyl esters profile page.


Drug patent expirations by year for OMEGA-3-ACID ETHYL ESTERS

Pharmacology for OMEGA-3-ACID ETHYL ESTERS

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Amneal PharmsOMEGA-3-ACID ETHYL ESTERSomega-3-acid ethyl estersCAPSULE;ORAL204940-001Nov 27, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaOMEGA-3-ACID ETHYL ESTERSomega-3-acid ethyl estersCAPSULE;ORAL203893-001Sep 19, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncOMEGA-3-ACID ETHYL ESTERSomega-3-acid ethyl estersCAPSULE;ORAL090973-001Sep 30, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par Pharm IncOMEGA-3-ACID ETHYL ESTERSomega-3-acid ethyl estersCAPSULE;ORAL091018-001Jun 24, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaOMEGA-3-ACID ETHYL ESTERSomega-3-acid ethyl estersCAPSULE;ORAL091028-001Apr 7, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: